AMMF’s Virtual 2021 European Cholangiocarcinoma Conference
Highlights from AMMF’s Virtual European Cholangiocarcinoma Conference 2021
AMMF’s BASL-endorsed annual cholangiocarcinoma (CCA) conference was held virtually for the first time this year. On 13–14 May 2021 AMMF brought together an expert faculty and speakers to deliver an engaging online event which had a specific European focus.
The conference was open for all with an interest in CCA, including specialists, scientists, researchers, patients and carers. A total of 620 delegates from six continents registered and over the two days, 26 presentations were delivered, plus 10 live Q&A sessions. Throughout both days, HCPs could visit the virtual poster hall to see and hear 17 poster presentations, and also visit the exhibition hall to meet AMMF’s sponsors, supporters and representatives of fellow CCA societies from around the world.
Day One: CCA Overviews, diagnosis and treatment updates
Highlights on Day One included updates on the AMMF Data Project which is showing a robust evidence base around diagnostic and treatment pathways for CCA in England. Data from this project also strengthens the case for dedicated Centres of Expertise, which was covered in another insightful presentation. The much-anticipated presentation on transplantation highlighted that with careful patient selection and rigorous treatment protocols, liver transplantation for CCA is possible and is now planned to be an option in the near future.
There was an extremely useful Nutrition session for patients and carers, plus an Ask the Expert sessions with a world class panel.
Also looking to the future, the transition towards precision medicine was explored, with updates on molecular profiling and targeted therapy for CCA.
To view Day One’s presentations
All the conference sessions were recorded and are now available to view.
To see the Day One programme, with presentation titles and speakers’ names, click here
To view Day One presentations, including the Q&A sessions, follow these links:
Session 1: Welcome and overviews
Session 2: Diagnostic and treatment updates
Day Two: International aspects of CCA and scientific updates
On the second day of the conference, delegates heard presentations from China, Southeast Asia, across Europe and the Netherlands. These international insights, together with the presentation on the work and initiatives of the European Network for the study of Cholangiocarcinoma (ENS-CCA) highlighted the ongoing and increasing collaboration in the field.
Scientific updates were delivered by researchers from six of the projects funded by AMMF and these, as well as the scientific updates on experimental modelling, shone a light on the efforts that are being made to understand the complexity of CCA and to develop new diagnostic tools and therapies which will hopefully lead to improved patient outcomes.
To view Day Two’s presentations
All the conference sessions were recorded and are now available to view.
To see the Day Two programme, with presentation titles and speakers’ names, click here
To view Day Two presentations, including the Q&A sessions, follow these links:
Session 3: Introduction to day two
Session 4: International aspects of CCA
Session 5: Scientific updates – AMMF funded research
Session 6: Scientific updates and developments
Shown at AMMF’s conference for the first time, the new animated film,
“Cholangiocarcinoma and the importance of molecular testing”
Update April 2022: As well as English, the animation is now available in French, German and Polish. To access these, please click here.
Abstracts 2021
All the posters and presentations given in the Poster Hall at AMMF’s virtual European Cholangiocarcinoma Conference 2021, can now be seen by clicking here
Please note: This area is intended for HCPs only.
AMMF thanks the following for their generous support for the European Cholangiocarcinoma Conference 2021:
SAVE THE DATE!
Join us next year for AMMF’s 2022 European Cholangiocarcinoma Conference 11 -13 May, 2022. For more information, click here
